Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy

Appendix S1. Figure S1. Figure S2. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.